<DOC>
	<DOCNO>NCT00942773</DOCNO>
	<brief_summary>The purpose study : - Evaluate influence CYP2C19 genotype PK profile voriconazole .</brief_summary>
	<brief_title>Influence CYP2C19 Genotype Pharmacokinetics ( PK ) Voriconazole</brief_title>
	<detailed_description />
	<mesh_term>Voriconazole</mesh_term>
	<criteria>1 . Healthy male subject age 20 50 year . 2 . A body mass index ( BMI ) range 1728 kg/m2 . 3 . Sufficient ability understand nature study hazard participate . Provide write informed consent fully . inform study procedure . 1 . Presence history severe adverse reaction drug history severe allergic disease . 2 . Clinically relevant abnormal medical history could interfere objective study . 3 . Presence history eye disease eye field defect . 4 . A subject history gastrointestinal disease surgery ( except simple appendectomy repair hernia ) , influence absorption study drug . 5 . A subject whose liver function test ( AST , ALT , GGT , ALP , LDH ) result 1.25 time upper limit normal range . 6 . A subject whose SBP 140 mmHg 90 mmHg DBP 100 mmHg 50 mmHg . 7 . Presence history drug abuse . 8 . Participation clinical trial within 2 month . 9 . Use prescription medicine , herbal medicine within 2 week overthecounter medication within 1 week first dose . 10 . Blood donation 2 month apheresis 1 month study . 11 . Presence history alcohol abuse . 12 . Smoking 10 cigarettes/day . 13 . Use grapefruit juice , xanthine contain beverage , alcohol smoking restriction period . 14 . Subject judge eligible study participation investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Healthy volunteer</keyword>
</DOC>